MetAlert, Inc. (MLRT) Going into 2023 in a Much Healthier Position after Eliminating All Toxic Debt in Q4 2022 and Launching New Remote Patient Monitoring Medical Devices

Dec 16, 2022

  • Ludlow Research ups price target for MetAlert, leading developer of location-sensitive health monitoring devices and wearable technology products, anticipating target between $1 and $1.25 per share
  • MetAlert announced the elimination of all its toxic convertible notes from its balance sheet, which now provides increased stability to its public float
  • The company also shared improved guidance to its NFC operations while also announcing the launch of new medical devices geared toward the geriatric and autism healthcare markets
  • Q4 2022 also saw the influx of new chips, which will significantly increase production of the company’s SmartSole units in early 2023, ramp up production and fulfilling of backorders currently in place, and increase revenues in the coming months
  • These moves present a unique opportunity for investors to capitalize on the impending price surges

New York based equity research firm Ludlow Research, has updated its research opinion for MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products. MetAlert just marked a successful fourth quarter of the 2022 financial year (“Q4 2022”), with the elimination of all toxic convertible notes (“TCN”) from its balance sheet. In what promises increased opportunities for its investors, MetAlert also shared improved guidance to their Near Field Communication (“NFC”) operations while also announcing the launch of new medical devices geared toward the geriatric and autism healthcare markets (https://ibn.fm/vAwkE).

TCN, also referred to as toxic debt, often converts at deep discounts to market price, ultimately contributing to shareholder dilution and price instability for small issuers. As a result, it can be detrimental to a company’s financial health. With MetAlert having eliminated all of its toxic debt, its management is…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork.

More News

WNBA offseason begins with search for first commissioner
Nov 1, 2026

WNBA offseason begins with search for first commissioner

UNCASVILLE, Connecticut — With Golden State the newly crowned WNBA champion, the league turns its attention to a pivotal offseason. Unlike last year when a new collective bargaining agreement dominated the offseason, the top priority is finding new leadership. Outgoing Commissioner Cathy Engelbert, who has been in the position nearly seven years, announced last month that she was retiring at the end of the calendar with year. A search has begun and the next commissiner will inherit a host of issues, including officiating, the transgender debate scheduling and improving a strained relationship with players. Here's a look at some of the main topics that will be center stage over the next few months before the season tips off again next May with a 50-game schedule: Improving relationship with players The league thrived in many ways during Engelbert's tenure. Under her leadership, the WNBA enjoyed record growth and popularity, and signed a record-breaking broadcasting deal. Players surpassed million-dollar annual salaries. But despite her accomplishments, Engelbert's relationship with players cordial at best, confrontational at other times. Breanna Stewart may have summed it up best when said that players “respect” Engelbert. Building a stronger relationship with players will likely be one of the first things on the new commissioner's to-do list. Officiating improvements Complaints about officiating felt like it reached a crescendo this season. The WNBA is taking various steps to address the situation. The league is opening a the new officiating replay center. The WNBA, along with the NBA, completed a multi-million dollar renovation in New Jersey to the official replay center. It will be fully operational next season. The WNBA is working to upgrade techonology and video infrastructure at arenas to help the process. There were improvements this year after a rough start to the season where teams struggled to adjust to the emphasis on players' freedom of movement. The league put together a task force, which Minnesota coach Cheryl Reeve is on, in the offseason to help clean up some of the physicality in the game. The main point of emphasis was to help players’ freedom of movement. Despite some hiccups early on, it has led to more offense as teams are averaging around 86 points a game — the highest ever. Scheduling challenges WNBA teams will play a record 50 games next season. It helps that there's no break for either the women's FIBA World Cup or the Olympics. Still the playoffs could once again go into the start of the NBA season. Nearly every team will be playing in an NBA arena next season with a few exceptions. To avoid a repeat of this year where Game 6 of the WNBA Finals was played at 12:30 p.m. EDT because of arena availability, the teams need to lock in potential playoff dates way ahead of time. Transgender debate The WNBA has criticized those trying to create a narrative about transgender women playing in the league. “There are no immediate eligibility matters affecting the WNBA, and we strongly denounce the bad-faith efforts to use these topics to demean or marginalize others,” a league spokesperson said in August after an anti-hate task force met virtually and discussed a variety of topics, including social media vitriol and transgender athletes. The league’s collective bargaining agreement states that “only players who are women are eligible to play in the WNBA,” but it does not include any more specific language about gender identity or sex assigned at birth. Two former NBA players, Enes Kanter Freedom and Royce White, declared themselves eligible for the WNBA draft, saying they identify as women. The league has said they aren't eligible. Welcome back Houston Comets The Connecticut Sun will relocate to Houston as the Comets will return after folding in 2008. The Sun were bought by the Houston Rockets ownership group led by Tilman Fertitta for $300 million. The Comets will begin play next season and are tied with Toronto for the best chance to win the WNBA draft lottery that will be held on Nov. 15. While the Sun relocated to Houston, there will be no expansion teams entering the league next year. Cleveland will enter in 2028, Detroit in 2029 and Philadelphia in 2030.

Yamaha pulls out of Qatar MotoGP over 'Middle East situation'
Nov 1, 2026

Yamaha pulls out of Qatar MotoGP over 'Middle East situation'

SEPANG, Malaysia — Yamaha said on Sunday it won't participate in next weekend's Qatar MotoGP, citing "the situation in the Middle East". "Yamaha has not identified sufficient grounds to change its existing company-wide travel restrictions," the Japanese manufacturer said. Among the racers on the MotoGP grid riding Yamaha bikes is France's Fabio Quartararo, the 2021 world champion. The MotoGP Group said it was "disappointed" by the decision and said that "Yamaha's non-participation also carries sporting implications". "While we recognize the team is subject to a broader corporate policy restricting travel to the Middle East, we do not believe this decision reflects the extensive assurances provided to all championship stakeholders," it said. MotoGP said talks with Qatari organizers and safety advisers had not flagged any reasons to change plans for the event. "We communicated that position, together with the latest available information, to all manufacturers and teams today and welcome the confirmation from the remainder of the grid that they will compete in Qatar, and we thank them for that commitment," the MotoGP Group said. The statements came shortly after the Malaysian MotoGP in Sepang, after which there are just three races left in the season, starting in Qatar. Ducati's reigning seven-time world champion Marc Marquez won the race at Sepang and could clinch the title in Doha. Several riders declined to talk afterwards about the Qatar race. According to reports, there was haggling behind the scenes in Sepang about whether teams would go to Qatar.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.